HLA alleles and haplotypes in Iran Tabriz Azeris population: genes and languages do not correlate.


Journal

Human immunology
ISSN: 1879-1166
Titre abrégé: Hum Immunol
Pays: United States
ID NLM: 8010936

Informations de publication

Date de publication:
Jun 2022
Historique:
received: 05 04 2022
revised: 06 04 2022
accepted: 06 04 2022
pubmed: 24 4 2022
medline: 18 5 2022
entrez: 23 4 2022
Statut: ppublish

Résumé

Azeri people are at present day mainly living in an area which comprises North (Azerbaijan) and South (Azeri Iran provinces) parts, living the biggest population in Azeri Iran provinces with about 17-20 million people. They were studied HLA-A, -B, -DRB1 and -DQB1 allele and extended haplotype frequencies in unrelated Iranian Tabriz Azeris from a rural area close to Tabriz City. The HLA extended haplotypes with highest frequencies are: 1) HLA- A*24:02-B*35:01-DRB1*11:01-DQB1*03:01, shared with Mediterraneans and southern Russians (Chuvash, which also show Mediterranean characters); and 2) HLA-A*01:02-B*08:01-DRB1*03:01-DQB1*02:01, found also in Chuvash and other Azeri samples from Tabriz. Neí's DA HLA-DRB1 genetic distances, HLA-DRB1 Neighbour-Joining dendrogram and Vista analyses show that population with closest distance is Kurdish, followed by Iranian Gorgan and Southern Russia/ North Caucasus Chuvash; probably these latter groups and Azeris were populating North Mesopotamia/ Caucasus Mts. since prehistoric times. Kurds (in Iraq and Iran) do not speak Turk while Azeris do: they are both genetically close, but they are not genetically close to present day Anatolia (Turkey) Turks who also speak Turk language and show a typical Mediterranean HLA profile. In summary, Azeri population studies show examples that genes and languages do not correlate, contradicting the postulate asserted by others.

Identifiants

pubmed: 35459551
pii: S0198-8859(22)00072-6
doi: 10.1016/j.humimm.2022.04.002
pii:
doi:

Substances chimiques

HLA-A Antigens 0
HLA-B Antigens 0
HLA-DQ beta-Chains 0
HLA-DRB1 Chains 0
Histocompatibility Antigens 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

477-479

Informations de copyright

Copyright © 2022 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Antonio Arnaiz-Villena (A)

Department of Immunology, University Complutense of Madrid, Spain. Electronic address: aarnaiz@med.ucm.es.

José Palacio-Gruber (J)

Department of Immunology, University Complutense of Madrid, Spain.

Ali Amirzargar (A)

Molecular Immunology Research Center, Medical School, Tehran University of Medical Sciences, Tehran, Iran.

Christian Vaquero-Yuste (C)

Department of Immunology, University Complutense of Madrid, Spain.

Marta Molina-Alejandre (M)

Department of Immunology, University Complutense of Madrid, Spain.

Alejandro Sánchez-Orta (A)

Department of Immunology, University Complutense of Madrid, Spain.

Alba Heras (A)

Department of Immunology, University Complutense of Madrid, Spain.

Behrouz Nikbin (B)

Molecular Immunology Research Center, Medical School, Tehran University of Medical Sciences, Tehran, Iran.

Fabio Suarez-Trujillo (F)

Department of Immunology, University Complutense of Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH